BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26702937)

  • 1. Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia.
    Betensky M; Babushok D; Roth JJ; Mason PJ; Biegel JA; Busse TM; Li Y; Lind C; Papazoglou A; Monos D; Podsakoff G; Bessler M; Olson TS
    Cancer Genet; 2016; 209(1-2):1-10. PubMed ID: 26702937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.
    Katagiri T; Sato-Otsubo A; Kashiwase K; Morishima S; Sato Y; Mori Y; Kato M; Sanada M; Morishima Y; Hosokawa K; Sasaki Y; Ohtake S; Ogawa S; Nakao S;
    Blood; 2011 Dec; 118(25):6601-9. PubMed ID: 21963603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.
    Shah YB; Priore SF; Li Y; Tang CN; Nicholas P; Kurre P; Olson TS; Babushok DV
    Blood Adv; 2021 Aug; 5(16):3216-3226. PubMed ID: 34427585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False homozygous HLA genotyping results due to copy number neutral loss of heterozygosity in acquired aplastic anaemia.
    Heyrman B; De Becker A; Verheyden S; Demanet C
    BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28254831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphism array analysis of bone marrow failure patients reveals characteristic patterns of genetic changes.
    Babushok DV; Xie HM; Roth JJ; Perdigones N; Olson TS; Cockroft JD; Gai X; Perin JC; Li Y; Paessler ME; Hakonarson H; Podsakoff GM; Mason PJ; Biegel JA; Bessler M
    Br J Haematol; 2014 Jan; 164(1):73-82. PubMed ID: 24116929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients.
    Montes P; Kerick M; Bernal M; Hernández F; Jiménez P; Garrido P; Márquez A; Jurado M; Martin J; Garrido F; Ruiz-Cabello F
    Oncotarget; 2018 Dec; 9(97):36929-36944. PubMed ID: 30651926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia.
    Babushok DV; Perdigones N; Perin JC; Olson TS; Ye W; Roth JJ; Lind C; Cattier C; Li Y; Hartung H; Paessler ME; Frank DM; Xie HM; Cross S; Cockroft JD; Podsakoff GM; Monos D; Biegel JA; Mason PJ; Bessler M
    Cancer Genet; 2015 Apr; 208(4):115-28. PubMed ID: 25800665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
    Marescalco MS; Capizzi C; Condorelli DF; Barresi V
    J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.
    Imi T; Katagiri T; Hosomichi K; Zaimoku Y; Hoang Nguyen V; Nakagawa N; Tajima A; Yoshizato T; Ogawa S; Nakao S
    Blood Adv; 2018 May; 2(9):1000-1012. PubMed ID: 29720492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic Anemia.
    Zaimoku Y; Katagiri T; Nakagawa N; Imi T; Maruyama H; Takamatsu H; Ishiyama K; Yamazaki H; Miyamoto T; Nakao S
    Transplant Cell Ther; 2024 Mar; 30(3):281.e1-281.e13. PubMed ID: 37972732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mosaicism for copy-neutral loss of heterozygosity and DNA copy number variations in the human genome.
    Žilina O; Koltšina M; Raid R; Kurg A; Tõnisson N; Salumets A
    BMC Genomics; 2015 Sep; 16(1):703. PubMed ID: 26376747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia.
    Maruyama H; Katagiri T; Kashiwase K; Shiina T; Sato-Otsubo A; Zaimoku Y; Maruyama K; Hosokawa K; Ishiyama K; Yamazaki H; Inoko H; Ogawa S; Nakao S
    Exp Hematol; 2016 Oct; 44(10):931-939.e3. PubMed ID: 27250585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphism array-based karyotyping shows sequential genomic changes from monosomy to copy-neutral loss of heterozygosity of chromosome 7 and 20q deletion within a balanced translocation t(14;20) in AML.
    Huh J; Mun YC; Seong CM; Chung WS
    Cancer Genet; 2011 Dec; 204(12):682-6. PubMed ID: 22285021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
    Zaimoku Y; Patel BA; Adams SD; Shalhoub R; Groarke EM; Lee AAC; Kajigaya S; Feng X; Rios OJ; Eager H; Alemu L; Quinones Raffo D; Wu CO; Flegel WA; Young NS
    Blood; 2021 Dec; 138(26):2799-2809. PubMed ID: 34724566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune pathophysiology of bone marrow failure].
    Hosokawa K
    Rinsho Ketsueki; 2023; 64(9):908-915. PubMed ID: 37793865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of 6pLOH in an aplastic anemia patient by in phase HLA genotyping.
    Kikkawa E; Shiina T; Shigenari A; Ozaki Y; Suzuki S; Ando K; Onizuka M
    HLA; 2020 May; 95(5):465-469. PubMed ID: 31970935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acquired aplastic anemia].
    Hosokawa K; Nakao S
    Rinsho Ketsueki; 2019; 60(5):417-422. PubMed ID: 31168007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
    Zhang JL; Liu TF; Chang LX; Chen X; Ren YY; Sun CC; Liu C; An WB; Wan Y; Chen XJ; Yang WY; Wang SC; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):27-33. PubMed ID: 28100318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.